First Census of Patients with Hereditary Angioedema in the Canary Islands.
Alejandro Mendoza-AlvarezItahisa Marcelino-RodriguezLourdes Almeida-QuintanaElena Martin-FernandezDara Martinez-BeltranZulay Almeida-SanchezDavid Cruz-NiesvaraGuacimara Hernández-SantanaJose C Garcia-RobainaCarlos FloresAriel Callero VieraPublished in: Journal of clinical medicine (2021)
Hereditary angioedema (HAE) is a rare genetic condition whose main symptoms are recurrent swelling in the skin, mucosa, and internal organs. Recent studies suggested that the regulation of the inflammatory response and the complement cascade are two of the pathways significantly enriched in the Canary Islands, Spain. Here, we describe the first HAE patient series in this region. Forty-one patients (33 F, 8 M) and nine healthy relatives belonging to twenty-nine families were recruited for this study, obtaining their clinical and demographic features using a data collection form, as well as blood samples for biochemical analysis. The mean age of patients was 36.8 years (ranging from 4 to 72 years). Positive family history of HAE was reported in 13 patients (32.5%), and a mean diagnosis delay of 7.9 (±12.5) years was estimated, ranging from months to 50 years. Cutaneous edema was the most common symptom (53.6%), while airway symptoms was present in 11 patients. Prophylactic treatment was indicated for 23 patients, while 14 also require on-demand rescue treatment. We estimate a minimum prevalence of 1.25:100,000 for HAE due to C1-INH deficiency or dysfunction in the Canary Islands, which is higher than the estimates for mainland Spanish populations. HAE continues to be a disease poorly recognized by health care professionals due to its confusing symptoms, leading to longer diagnosis delay. Altogether, the evidence reinforces the need for a rapid and accurate diagnosis and precision medicine-based studies to improve the patient's quality of life.
Keyphrases
- end stage renal disease
- ejection fraction
- healthcare
- newly diagnosed
- inflammatory response
- oxidative stress
- peritoneal dialysis
- patient reported
- risk factors
- deep learning
- artificial intelligence
- mass spectrometry
- physical activity
- angiotensin ii
- soft tissue
- lps induced
- combination therapy
- replacement therapy
- quantum dots
- health insurance